Phibro Animal Health (PAHC) EBIT (2012 - 2026)

Phibro Animal Health's EBIT history runs 15 years deep, the most recent figure standing at $44.7 million for Q1 2026.

• In Q1 2026, EBIT rose 33.23% year-over-year to $44.7 million; the TTM figure through Mar 2026 stood at $180.0 million (up 89.1% YoY), while the FY2025 annual figure was $110.5 million, up 107.19% from the prior year.
• EBIT was $44.7 million for Q1 2026 at Phibro Animal Health, down from $50.3 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $51.3 million in Q3 2025 to a low of -$726000.0 in Q3 2023.
• Historically, EBIT has averaged $24.9 million across 5 years, with a median of $19.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: EBIT plunged 105.31% in 2023, then surged 2537.88% in 2024.
• A 5-year view of EBIT shows it stood at $15.8 million in 2022, then declined by 0.9% to $15.7 million in 2023, then jumped by 62.62% to $25.5 million in 2024, then surged by 97.1% to $50.3 million in 2025, then slipped by 11.27% to $44.7 million in 2026.
• The last three EBIT figures came in at $44.7 million (Q1 2026), $50.3 million (Q4 2025), and $51.3 million (Q3 2025), per Business Quant data.